SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-060478
Filing Date
2024-05-15
Accepted
2024-05-15 16:15:28
Documents
43
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mack-20240331.htm   iXBRL 10-Q 730346
2 EX-31.1 mack-ex31_1.htm EX-31.1 11103
3 EX-31.2 mack-ex31_2.htm EX-31.2 11103
4 EX-32.1 mack-ex32_1.htm EX-32.1 7288
5 EX-32.2 mack-ex32_2.htm EX-32.2 7288
  Complete submission text file 0000950170-24-060478.txt   3409520

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mack-20240331.xsd EX-101.SCH 524801
47 EXTRACTED XBRL INSTANCE DOCUMENT mack-20240331_htm.xml XML 490275
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35409 | Film No.: 24950933
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)